BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20107154)

  • 21. Insertion of MLL sequences into chromosome band 5q31 results in an MLL-AF5Q31 fusion and is a rare but recurrent abnormality associated with infant leukemia.
    Deveney R; Chervinsky DS; Jani-Sait SN; Grossi M; Aplan PD
    Genes Chromosomes Cancer; 2003 Jul; 37(3):326-31. PubMed ID: 12759932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloperoxidase gene expression in non-infant pro-B acute lymphoblastic leukaemia with or without ALL1/AF4 transcript.
    Serrano J; Lo Coco F; Sprovieri T; Elia L; Vitale A; Gregorj C; Tafuri A; Sánchez J; Román J; Torres A; Cimino G
    Br J Haematol; 2000 Dec; 111(4):1065-70. PubMed ID: 11167741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling of adult t(4;11)(q21;q23)-associated acute lymphoblastic leukemia reveals a different signature from pediatric cases.
    De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Basinko A; Morel F; De Braekeleer M
    Anticancer Res; 2012 Sep; 32(9):3893-9. PubMed ID: 22993334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.
    Bursen A; Schwabe K; Rüster B; Henschler R; Ruthardt M; Dingermann T; Marschalek R
    Blood; 2010 Apr; 115(17):3570-9. PubMed ID: 20194896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical analysis of newly diagnosed acute lymphoblastic leukemia with 11q23/MLL gene rearrangement].
    Wang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1092-1096. PubMed ID: 32924108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia.
    Elia L; Gottardi E; Floriddia G; Grillo R; Ciambelli F; Luciani M; Chiusolo P; Invernizzi R; Meloni G; Foà R; Saglio G; Cimino G
    Leukemia; 2004 Nov; 18(11):1824-30. PubMed ID: 15318246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia.
    Koh K; Tomizawa D; Moriya Saito A; Watanabe T; Miyamura T; Hirayama M; Takahashi Y; Ogawa A; Kato K; Sugita K; Sato T; Deguchi T; Hayashi Y; Takita J; Takeshita Y; Tsurusawa M; Horibe K; Mizutani S; Ishii E
    Leukemia; 2015 Feb; 29(2):290-6. PubMed ID: 24888273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A translocation in acute lymphoblastic leukemia that cytogenetically mimics the recurrent MLL-AFF1 translocation and fuses SEPT11 to MLL.
    Stevens SJ; Meers LE; Albrechts JC; Mebis-Verhees K; Bos GM; Engelen JJ; Janssen JW
    Cancer Genet Cytogenet; 2010 Aug; 201(1):48-51. PubMed ID: 20633769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.
    Ahmad K; Scholz B; Capelo R; Schweighöfer I; Kahnt AS; Marschalek R; Steinhilber D
    Oncotarget; 2015 Sep; 6(28):25784-800. PubMed ID: 26329759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
    Rubnitz JE; Camitta BM; Mahmoud H; Raimondi SC; Carroll AJ; Borowitz MJ; Shuster JJ; Link MP; Pullen DJ; Downing JR; Behm FG; Pui CH
    J Clin Oncol; 1999 Jan; 17(1):191-6. PubMed ID: 10458233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
    Elia L; Grammatico S; Paoloni F; Vignetti M; Rago A; Cenfra N; Mecarocci S; Mancini M; Luciani M; Di Raimondo F; Cazzaniga G; Matarazzo M; Moleti ML; Santoro L; Gaidano G; Foà R; Mandelli F; Cimino G
    Am J Hematol; 2011 Dec; 86(12):993-7. PubMed ID: 21953510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
    Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Brunet S; Bergua J; Tormo M; García-Boyero R; Sarrà J; Del Potro E; Grande C; Barba P; Bernal T; Amigo ML; Grau J; Cervera J; Feliu E;
    Leuk Lymphoma; 2017 Jan; 58(1):145-152. PubMed ID: 27122129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of co-expressed genes associated with MLL rearrangement in pediatric acute lymphoblastic leukemia.
    Zhang H; Liu B; Cheng J; Ma H; Li Z; Xi Y
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.
    Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G
    Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mixed lineage leukemia (MLL) fusion-associated gene AF4 promotes CD133 transcription.
    Mak AB; Nixon AM; Moffat J
    Cancer Res; 2012 Apr; 72(8):1929-34. PubMed ID: 22337994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial.
    Marks DI; Moorman AV; Chilton L; Paietta E; Enshaie A; DeWald G; Harrison CJ; Fielding AK; Foroni L; Goldstone AH; Litzow MR; Luger SM; McMillan AK; Racevskis J; Rowe JM; Tallman MS; Wiernik P; Lazarus HM
    Haematologica; 2013 Jun; 98(6):945-52. PubMed ID: 23349309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis.
    Kersey JH; Wang D; Oberto M
    Leukemia; 1998 Oct; 12(10):1561-4. PubMed ID: 9766500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96).
    Isoyama K; Eguchi M; Hibi S; Kinukawa N; Ohkawa H; Kawasaki H; Kosaka Y; Oda T; Oda M; Okamura T; Nishimura S; Hayashi Y; Mori T; Imaizumi M; Mizutani S; Tsukimoto I; Kamada N; Ishii E
    Br J Haematol; 2002 Sep; 118(4):999-1010. PubMed ID: 12199778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusion of an AF4-related gene, LAF4, to MLL in childhood acute lymphoblastic leukemia with t(2;11)(q11;q23).
    Hiwatari M; Taki T; Taketani T; Taniwaki M; Sugita K; Okuya M; Eguchi M; Ida K; Hayashi Y
    Oncogene; 2003 May; 22(18):2851-5. PubMed ID: 12743608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression.
    Bertrand FE; Spengeman JD; Shah N; LeBien TW
    Leukemia; 2003 Dec; 17(12):2454-9. PubMed ID: 14562113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.